BSE Code: | NSE Symbol: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
BSE
551.35
Change Change %
3.35 0.61%

Updated:17 Apr, 2014, 15:52 PM IST

NSE
551.00
Change Change %
3.20 0.58%

Updated:17 Apr, 2014, 15:59 PM IST

Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

528.00556.05

52 Wk Range

138.45 575.95
Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

527.20 555.80

52 Wk Range

138.35 575.75

Compare Price performance of vs. Peer Companies

From sector

Compare with Peers on Key Fundamentals and Financials

Color code for Price performance of and Peer companies

  • 5% and above
  • 2% to 5%
  • 0.5% to 2%
  • -0.5% to 0.5%
  • -2% to -0.5%
  • -5% to -2%
  • -5% and below

's Latest Research Report

Brokerage/Analyst Report Date Call Price@Call Target Current Status Report
Bank of America Merrill Lynch
-
31-12-2013 Buy 391.50 450.00 Target Hit Details
Bank of America Merrill Lynch
-
29-11-2013 Buy 295.00 425.00 Target Hit Details

Aurobindo Pharma's Key Fundamentals

ParameterValues
Market Cap (in ₹ Cr.)16,059.28
Earning Per Share (EPS TTM) (₹)31.11
Price To Earnings (P/E) Ratio17.71
Book Value Per Share (₹)100.93
Price To Books (P/B) Ratio5.46
EBIT Margin (%)14.60
PAT Margin (%)8.91
ROCE (%)14.77
PAT Growth (%)1264.02
Total Debt to Equity (D/E) Ratio0.95

More from Key Fundamentals »

Aurobindo Pharma's Financial Summary

Parameter MAR'13
(₹ Cr.)
MAR'12
(₹ Cr.)
YoY
%Change
Balance Sheet:
Share Capital 29.12 29.11 0.03%
Total Non-Current Liabilities 1,117.50 841.66 32.77%
Total Current Liabilities 2,767.97 2,656.38 4.20%
Total Liabilities 6,824.57 5,991.21 13.91%
Total Non-Current Assets 3,193.87 2,973.75 7.40%
Currents Investments 0.04 18.68 -99.79%
Cash and Bank 114.57 14.01 717.77%
Total Current Assets Excluding Current Investments 3,630.66 2,998.78 21.07%
Total Assets 6,824.57 5,991.21 13.91%
Profit and Loss:
Gross Sales 5,569.50 4,378.73 27.19%
Net Sales 5,425.10 4,281.45 26.71%
PBIDT (Excl OI) 958.06 573.49 67.06%
PAT 495.99 -42.61 -1264.02%

More from Financial Summary

Aurobindo Pharma's Shareholding Pattern

's Futures and Options Quotes

Contract
Expiry Date
Type Current price Change Change % Premium / Discount
AUROPHARMA
24-04-2014
FUTSTK
552.001.85 0.34% 1.00
AUROPHARMA
29-05-2014
FUTSTK
557.752.75 0.50% 6.75
AUROPHARMA
26-06-2014
FUTSTK
557.30-9.25 -1.63% 6.30

More from Futures and Options Quotes »

Post your comments about Aurobindo Pharma